Visiomed Group SA
PAR:ALVMG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Visiomed Group SA
Total Equity
Visiomed Group SA
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Visiomed Group SA
PAR:ALVMG
|
Total Equity
€24.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
132%
|
CAGR 10-Years
16%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Total Equity
€23.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Biomerieux SA
PAR:BIM
|
Total Equity
€4.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Total Equity
€12.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Total Equity
€6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Total Equity
€94.7m
|
CAGR 3-Years
19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Visiomed Group SA
Glance View
Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.
See Also
What is Visiomed Group SA's Total Equity?
Total Equity
24.1m
EUR
Based on the financial report for Dec 31, 2023, Visiomed Group SA's Total Equity amounts to 24.1m EUR.
What is Visiomed Group SA's Total Equity growth rate?
Total Equity CAGR 10Y
16%
Over the last year, the Total Equity growth was -1%.
